Annual EBITDA
-$20.16 M
+$16.20 M+44.55%
31 December 2023
Summary:
Coeptis Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$20.16 million, with the most recent change of +$16.20 million (+44.55%) on 31 December 2023. During the last 3 years, it has fallen by -$11.47 million (-132.10%). COEP annual EBITDA is now -132.10% below its all-time high of -$8.68 million, reached on 01 December 2020.COEP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.50 M
+$1.22 M+44.84%
01 September 2024
Summary:
Coeptis Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.50 million, with the most recent change of +$1.22 million (+44.84%) on 01 September 2024. Over the past year, it has increased by +$4.55 million (+75.21%). COEP quarterly EBITDA is now at all-time high.COEP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$10.29 M
+$4.55 M+30.66%
01 September 2024
Summary:
Coeptis Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$10.29 million, with the most recent change of +$4.55 million (+30.66%) on 01 September 2024. Over the past year, it has increased by +$8.99 million (+46.64%). COEP TTM EBITDA is now -437.43% below its all-time high of -$1.91 million, reached on 01 March 2021.COEP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COEP EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.5% | +75.2% | +46.6% |
| 3 y3 years | -132.1% | +39.4% | +19.7% |
| 5 y5 years | - | - | - |
COEP EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -132.1% | +44.5% | at high | +92.0% | at high | +71.9% |
| 5 y | 5 years | -132.1% | +44.5% | at high | +92.0% | -437.4% | +71.9% |
| alltime | all time | -132.1% | +44.5% | at high | +92.0% | -437.4% | +71.9% |
Coeptis Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.50 M(-44.8%) | -$10.29 M(-30.7%) |
| June 2024 | - | -$2.72 M(+6.6%) | -$14.84 M(-1.3%) |
| Mar 2024 | - | -$2.55 M(-27.6%) | -$15.03 M(-25.4%) |
| Dec 2023 | -$20.16 M(-44.6%) | -$3.52 M(-41.8%) | -$20.16 M(+4.5%) |
| Sept 2023 | - | -$6.05 M(+107.9%) | -$19.29 M(+3.8%) |
| June 2023 | - | -$2.91 M(-62.1%) | -$18.58 M(-26.2%) |
| Mar 2023 | - | -$7.68 M(+189.6%) | -$25.16 M(-30.8%) |
| Dec 2022 | -$36.35 M | -$2.65 M(-50.4%) | -$36.35 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$5.34 M(-43.7%) | -$36.18 M(-1.1%) |
| June 2022 | - | -$9.49 M(-49.7%) | -$36.59 M(+22.9%) |
| Mar 2022 | - | -$18.87 M(+663.3%) | -$29.77 M(+132.3%) |
| Dec 2021 | -$12.81 M(+47.6%) | - | - |
| Dec 2021 | - | -$2.47 M(-57.1%) | -$12.81 M(+23.9%) |
| Sept 2021 | - | -$5.76 M(+115.6%) | -$10.34 M(+125.6%) |
| June 2021 | - | -$2.67 M(+39.4%) | -$4.58 M(+139.4%) |
| Mar 2021 | - | -$1.91 M | -$1.91 M |
| Dec 2020 | -$8.68 M | - | - |
FAQ
- What is Coeptis Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual EBITDA year-on-year change?
- What is Coeptis Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly EBITDA year-on-year change?
- What is Coeptis Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Coeptis Therapeutics?
- What is Coeptis Therapeutics TTM EBITDA year-on-year change?
What is Coeptis Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of COEP is -$20.16 M
What is the all time high annual EBITDA for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$8.68 M
What is Coeptis Therapeutics annual EBITDA year-on-year change?
Over the past year, COEP annual earnings before interest, taxes, depreciation & amortization has changed by +$16.20 M (+44.55%)
What is Coeptis Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of COEP is -$1.50 M
What is the all time high quarterly EBITDA for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.50 M
What is Coeptis Therapeutics quarterly EBITDA year-on-year change?
Over the past year, COEP quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.55 M (+75.21%)
What is Coeptis Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of COEP is -$10.29 M
What is the all time high TTM EBITDA for Coeptis Therapeutics?
Coeptis Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.91 M
What is Coeptis Therapeutics TTM EBITDA year-on-year change?
Over the past year, COEP TTM earnings before interest, taxes, depreciation & amortization has changed by +$8.99 M (+46.64%)